Evidence map›Paper›PMID 29632194›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis.

Qibiao Wu, Yahui Tian, Jian Zhang, Xinyuan Tong, Hsinyi Huang, Shuai Li, Hong Zhao, Ying Tang, Chongze Yuan, Kun Wang and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 97 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Discovery and structural studies of histone demethylases.Frontiers in epigenetics and epigenomics · 2025
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. CRISPRingCancers · 2024
    Review
  15. Article
  16. Article
  17. The role and function of CLU in cancer biology and therapy.Clinical and experimental medicine · 2023
    Review
  18. Article
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 8 institutions in 2 countries.

Qibiao WuState Key Laboratory of Cell Biology, Innovation Center for Cell Signaling Network, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.
Yahui TianInstitute of Life and Health Engineering, Jinan University, Guangzhou, Guangdong 510632, China.
Jian ZhangState Key Laboratory of Cell Biology, Innovation Center for Cell Signaling Network, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.
Xinyuan TongState Key Laboratory of Cell Biology, Innovation Center for Cell Signaling Network, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.
Hsinyi HuangState Key Laboratory of Cell Biology, Innovation Center for Cell Signaling Network, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.
Shuai LiLaura & Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, NY 10016.
Hong ZhaoInstitute of Life and Health Engineering, Jinan University, Guangzhou, Guangdong 510632, China.
Ying TangState Key Laboratory of Cell Biology, Innovation Center for Cell Signaling Network, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.
Chongze YuanDepartment of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200031, China.
Kun WangKey Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China.
Zhaoyuan FangState Key Laboratory of Cell Biology, Innovation Center for Cell Signaling Network, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.
Lei GaoInstitute of Life and Health Engineering, Jinan University, Guangzhou, Guangdong 510632, China.
Xin HuThe University of Texas Graduate School in Biomedical Sciences, Houston, TX 77030.
Fuming LiState Key Laboratory of Cell Biology, Innovation Center for Cell Signaling Network, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.
Zhen QinState Key Laboratory of Cell Biology, Innovation Center for Cell Signaling Network, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.
Shun YaoState Key Laboratory of Cell Biology, Innovation Center for Cell Signaling Network, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.
Ting ChenLaura & Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, NY 10016.
Haiquan ChenDepartment of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200031, China.
Gong ZhangInstitute of Life and Health Engineering, Jinan University, Guangzhou, Guangdong 510632, China.
Wanting LiuInstitute of Life and Health Engineering, Jinan University, Guangzhou, Guangdong 510632, China.
Yihua SunDepartment of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200031, China.
Luonan ChenState Key Laboratory of Cell Biology, Innovation Center for Cell Signaling Network, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.
Kwok-Kin WongLaura & Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, NY 10016.
Kai GeLaboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892.ORCID 0000-0002-7442-5138
Liang ChenInstitute of Life and Health Engineering, Jinan University, Guangzhou, Guangdong 510632, China; chenliang@nibs.ac.cn hbji@sibcb.ac.cn.
Hongbin JiState Key Laboratory of Cell Biology, Innovation Center for Cell Signaling Network, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China; chenliang@nibs.ac.cn hbji@sibcb.ac.cn.
Center for Excellence in Molecular Cell Science · CNJinan University · CNNYU Langone Health · USShanghai Medical College of Fudan University · CNChinese Academy of Sciences · CNNational Institutes of Health · USShanghaiTech University · CNThe University of Texas MD Anderson Cancer Center · US

Funding

Regulation of PPARgamma Expression and Adipogenesis by PTIP-Associated FactorsZIADK075003 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI GE, KAI · 2009 to 2025
$17.6M
6 · The paper itself

Abstract

Lung cancer is the leading cause of cancer-related death worldwide. Inactivation of tumor suppressor genes (TSGs) promotes lung cancer malignant progression. Here, we take advantage of the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9-mediated somatic gene knockout in a

Indexed as

CRISPR-Cas SystemsEpigenesis, GeneticGene Expression Regulation, NeoplasticAnimalsCell Transformation, NeoplasticHistone DemethylasesHumansLung NeoplasmsMiceMice, KnockoutNeoplasms, ExperimentalProto-Oncogene Proteins p21(ras)Tumor Suppressor ProteinsHistone DemethylasesHras protein, mouseProto-Oncogene Proteins p21(ras)Tumor Suppressor ProteinsUtx protein, mouseCRISPR/Cas9 in vivo knockoutEZH2 inhibitornon-small cell lung cancertumor suppressor genesUTX

Identifiers

PMID29632194
PMCPMC5924887
OpenAlexW2796882889

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.